Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(9)
•••
Fruckedagain
X
View Profile
View Bullboard History
Comment by
Fruckedagain
on Jun 19, 2024 7:16pm
RE:RE:Happy Anniversary Howard
So. The bio has been presented to many companys to study and trial over the past 15 years. From cats to cancer to diabetes to skin lighnting to wrinkle to acne....and gawd knows what else. Every trial
...more
(80)
•••
bealert
X
View Profile
View Bullboard History
Comment by
bealert
on Jun 19, 2024 12:46pm
RE:Happy Anniversary Howard
May I join you, Pareto, in also extending congratulations to HowHee. Two years is now the new norm with Sirona, that way we can become more efficient and only have to check every two years if anything
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(2)
•••
theteddyfactor
X
View Profile
View Bullboard History
Post by
theteddyfactor
on Jun 19, 2024 12:23pm
Breakdown
Anyone know the % of salary capital raised and breakdown of management and staff. I really dont have a clue that represents SBM. In a perfect world, you would like to see 25-30 % on salary
...more
(75)
•••
Pareto8020
X
View Profile
View Bullboard History
Post by
Pareto8020
on Jun 19, 2024 10:50am
Happy Anniversary Howard
I missed congratulating Howard on the June 13th 2022 anniversary of the AbbVie deal. That was a real watershed for Sirona. Howard with next to no funds in the SBM coffers thought it
...more
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on Jun 19, 2024 5:52am
RE:V.SBM - What do I expect to happen next?
Possible.... But first, lets do a 1 year due diligence! So we can go back to sleep.
(4)
•••
TawiTwai
X
View Profile
View Bullboard History
Post by
TawiTwai
on Jun 19, 2024 2:40am
V.SBM - What do I expect to happen next?
What do I expect to happen next ? In a few days, when Stonegate’s investors and subscribers had time to review the report, I am certain they will want to get on the phone and pitch
...more
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Jun 18, 2024 11:54pm
RE:IDIOT SELLING AT 5.5 CENTS!
It would be very positive if you decide to buy at 7 cents! Just joking... But hey, maybe not!m The analysis released yesterday suggested a USD 12.5B market in North America. If you multiply that with
...more
(9)
•••
Fruckedagain
X
View Profile
View Bullboard History
Comment by
Fruckedagain
on Jun 18, 2024 8:04pm
RE:This sounds pretty good to me
They are sure buying a lot of stock....but then maybe they aren't because they don't want to lose the money they are being paid. Why be stupid? Time for the head donkey to put out a new
...more
(2096)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jun 18, 2024 7:46pm
RE:RE:This sounds pretty good to me
" In the quest to combat age-related skin concerns, we believe two groundbreaking topical agents, Pitera™ and GlycoProteMim™, will emerge as potential frontrunners. Both Pitera™ and GlycoProteMim
...more
(2096)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jun 18, 2024 7:43pm
RE:This sounds pretty good to me
" Novel Topicals like OneSkin, GlycoProteMim™ and Pitera™, will gain traction for their unique, scientifically-backed benefits. These novel topicals offer multi-faceted skin benefits — from deep
...more
(2096)
•••
tylerreddick
X
View Profile
View Bullboard History
Post by
tylerreddick
on Jun 18, 2024 7:38pm
This sounds pretty good to me
" We are especially excited about Sirona Biochem’s GlycoProteMim which operates on a fundamentally different principle than its predecessors. While Retinoids work by promoting cell turnover and
...more
(9)
•••
Fruckedagain
X
View Profile
View Bullboard History
Comment by
Fruckedagain
on Jun 18, 2024 7:37pm
RE:RE:New Press Release - GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report
There are none. and for years the science has been proven over and over again as non commercial. Look at how many supposed companys looked at it. Of course we can't verify it a all it has been
...more
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 18, 2024 6:14pm
RE:RE:New Press Release - GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report
example of Stonegate report on pre-revenue co...... https://stonegateinc.com/download/burcon-initiation/?wpdmdl=812&refresh=6630eb784e3821714482040
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 18, 2024 6:11pm
RE:New Press Release - GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report
Stonegate issues research reports with financial anaylsis and price targets for other co.s....Sirona mgmt won't offer any damn visibility on revenues or earnings so Stonegate had to do a industry
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden